Methylphenidate for Attention Problems After Pediatric TBI

• Status: Completed
• Trial end date: 2016-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Traumatic Brain Injury (TBI) - methylphenidate treatment

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital Medical Center, Cincinnati
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• Between ages of 6-17

• Sustained Moderate to Severe TBI

• TBI occurred at least 6 months prior to beginning the study

• TBI occurred no earlier than 5 years of age

• Positive endorsement of 6 out of 9 items on the Vanderbilt ADHD inattention or hyperactivity scale

Exclusion Criteria:

• History of developmental disability or mental retardation

• Current active participation in ADHD-related behavioral intervention

• History of psychiatric condition requiring an inpatient admission in past 12 months

• Actively taking medications with a contraindication to Concerta that cannot be discontinued

• Current use of stimulant medication or ADHD specific medications that cannot be discontinued

• Non-blunt head injury

• Family history of arrhythmia

• Pregnancy